Search
Crinetics Pharmaceuticals Inc
CRNXAdd to Watchlist
83.865USD
+0.135+0.16%
Close 07-27 16:00（ET）Quotes delayed by 15 min
8.83BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-27The current earnings forecast score of Crinetics Pharmaceuticals Inc is 8.50, ranking 107 out of 386 in the Biotechnology & Medical Research industry. The average price target is 83.00, with a high of 108.00 and a low of 45.00.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
81.500
Target Price
-2.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Crinetics Pharmaceuticals Inc
CRNX
15
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Crinetics Pharmaceuticals Inc's expected revenue for the next quarter?
Crinetics Pharmaceuticals Inc's expected revenue is 14.84M.
What is Crinetics Pharmaceuticals Inc's price target?
Analysts forecast that Crinetics Pharmaceuticals Inc's price target is USD 83.00, with the highest forecast at USD 108.00 and the lowest forecast at USD 45.00.
How have Crinetics Pharmaceuticals IncCRNX's recent earnings per share performed?
The market expectation was USD -1.23, while Crinetics Pharmaceuticals IncCRNX's earnings per share (EPS) for the previous quarter was USD -1.29. EPS for the next quarter is expected at USD -1.21.
What is the analyst rating for Crinetics Pharmaceuticals Inc?
Based on the ratings of Crinetics Pharmaceuticals Inc's stock from 15 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.